AAE, S., KA, M., L, V., LS, J., TB, C., LH, C., . . . P, G. (2026). Reduction of primary tumor growth and metastasis in models of triple-negative breast cancer following tilorone administration via type I interferon signaling. Breast cancer research : BCR, 28(1), . https://doi.org/10.1186/s13058-026-02296-7
Chicago Style (17th ed.) CitationAAE, Saunders, et al. "Reduction of Primary Tumor Growth and Metastasis in Models of Triple-negative Breast Cancer Following Tilorone Administration via Type I Interferon Signaling." Breast Cancer Research : BCR 28, no. 1 (2026). https://doi.org/10.1186/s13058-026-02296-7.
MLA (9th ed.) CitationAAE, Saunders, et al. "Reduction of Primary Tumor Growth and Metastasis in Models of Triple-negative Breast Cancer Following Tilorone Administration via Type I Interferon Signaling." Breast Cancer Research : BCR, vol. 28, no. 1, 2026, https://doi.org/10.1186/s13058-026-02296-7.